NEUROMAX

NEUROMAX 1,5% is a neurolitic of parenteral application exclusively; to be given subcutaneously, intramuscularly, and intra-articularly to rapidly inhibit the nervous transmission temporarily in the amielinic fibers type-C thanks to the Ammonium Ion acting through Ionic competence.

Benefits: NEUROMAX 1,5% is a neurolitic of parenteral application exclusively; to be given subcutaneously, intramuscularly, and intra-articularly to rapidly inhibit the nervous transmission temporarily in the amielinic fibers type-C thanks to the Ammonium Ion acting through Ionic competence. Its capacity to block the transmission is proportionally inverse to the width of the nerve fiber, thus, the dosage varies according to the diameter of the nerve to be treated.

Indications: Reversible block of nerve fibers. Neuralgia, myalgia. Myositis, muscular contracture. Articular degenerative disease. Bursitis. Synovitis. Periostitis. NEUROMAX NEUROMAX NEUROMAX NEUROMAX

Destination Species: Sport equines non destined to human food consumption.

Posology: Dosage depends on the area to be treated. Perineural application. Digital nerves 2 to 4 ml. Palmar nerves 3 to 5 ml. Superficial peroneal nerve 3 ml. Deep peroneal nerve 5 to 7 ml. Tibial nerve 5 to 7 ml. Dorsal Metacarpal/metatarsal periostitis and/or Intermetacarpal/intermetatarsal osteitis: 5 ml or more, according to Vet prescription. Intramuscular infiltrations: 5 ml x point of application, with a total 50 ml dose per croup, blade, or back. Antiinflammatory and local anesthetic drugs may be applied, according to Vet prescription. Repeat dosage as many times as necessary once the effects of the previous dose have disappeared, since –as different from the phenol-based neurolitics–the ammonium chloride solutions do not cause fibrosis in the point of application.

Presentation: Ampoule bottle x 50 ml.

Formula: Ammonium chloride. Excipient

NEUROMAX 1,5% is a neurolitic of parenteral application exclusively; to be given subcutaneously, intramuscularly, and intra-articularly to rapidly inhibit the nervous transmission temporarily in the amielinic fibers type-C thanks to the Ammonium Ion acting through Ionic competence. Its capacity to block the transmission is proportionally inverse to the width of the nerve fiber, thus, the dosage varies according to the diameter of the nerve to be treated.

NEUROMAX 1,5% is a neurolitic of parenteral application exclusively; to be given subcutaneously, intramuscularly, and intra-articularly to rapidly inhibit the nervous transmission temporarily in the amielinic fibers type-C thanks to the Ammonium Ion acting through Ionic competence. Its capacity to block the transmission is proportionally inverse to the width of the nerve fiber, thus, the dosage varies according to the diameter of the nerve to be treated. NEUROMAX NEUROMAX NEUROMAX NEUROMAX NEUROMAX NEUROMAX